New review of the first oral PCSK9 drug, a needle-free option for high cholesterol
A new review from Binghamton University School of Pharmacy and Pharmaceutical Science explores how Lipfendra (enlicitide) can be beneficial for those who have intolerances to injectable medications. The review was recently published in Annals of Pharmacotherapy and was authored by clinical assistant professors Taylor Clark, Rachel Lucas and Mia Lussier, as well as assistant professor Azadeh…
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
